Recent advances in percutaneous coronary intervention.

Heart
Stephen P Hoole, Paul Bambrough

Abstract

Percutaneous coronary intervention (PCI) continues to advance at pace with an ever-broadening indication. In this article we will review the recent technological advances in PCI that have enabled more complex coronary disease to be treated. The choice of revascularisation strategy must take into account the evidence-just because we can treat by PCI does not necessarily mean we should. When PCI is indicated, a safe, precision PCI approach guided by physiology, imaging and optimal lesion preparation should be the goal to obtain complete revascularisation and a durable long-term result. When these standards are adhered to, the outcomes can be excellent, in even complex coronary disease. We provide contemporary trial evidence to justify PCI and treatment algorithms that ensure optimal revascularisation decision making to achieve the best patient outcomes.

References

Nov 15, 2006·The New England Journal of Medicine·Bruno SchellerUlrich Speck
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Jan 16, 2009·The New England Journal of Medicine·Pim A L ToninoUNKNOWN FAME Study Investigators
Sep 3, 2013·The New England Journal of Medicine·David S WaldUNKNOWN PRAMI Investigators
Oct 16, 2015·The New England Journal of Medicine·Philip UrbanUNKNOWN LEADERS FREE Investigators
Nov 4, 2015·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Patrick A CalvertMartin R Bennett
Nov 1, 2016·The New England Journal of Medicine·Gregg W StoneUNKNOWN EXCEL Trial Investigators
Mar 21, 2017·The New England Journal of Medicine·Matthias GötbergUNKNOWN iFR-SWEDEHEART Investigators
Mar 21, 2017·The New England Journal of Medicine·Justin E DaviesJavier Escaned
Jun 15, 2017·Frontiers in Cardiovascular Medicine·Kara ShuttleworthStephen J Leslie
Aug 28, 2017·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Emanuele BarbatoAntonio Colombo
Nov 5, 2017·Journal of the American College of Cardiology·Dean J KereiakesUNKNOWN ABSORB III Investigators
Nov 5, 2017·Journal of the American College of Cardiology·Gregg W StonePatrick W Serruys
Dec 9, 2017·JACC. Cardiovascular Imaging·Akiko MaeharaGregg W Stone
Jan 18, 2018·Journal of cardiology·Jason NogicAdam J Brown
May 24, 2018·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Johan SvanerudZiad A Ali
Jul 12, 2018·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Julian Daniel WidderJohann Bauersachs
Aug 1, 2017·European Cardiology·Andrew McNeiceColm Hanratty
Dec 14, 2018·Nature Reviews. Cardiology·Hiroyuki JinnouchiAloke V Finn
Jan 15, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Alfredo R GalassiGeorgios Sianos
Jul 23, 2019·European Heart Journal·Nils P JohnsonKeith G Oldroyd
Aug 10, 2019·JACC. Cardiovascular Interventions·Giovanni Luigi De MariaAdrian P Banning
Sep 3, 2019·The New England Journal of Medicine·Shamir R MehtaUNKNOWN COMPLETE Trial Steering Committee and Investigators
Sep 27, 2019·The New England Journal of Medicine·Roxana MehranC Michael Gibson
Sep 29, 2019·The New England Journal of Medicine·Gregg W StoneUNKNOWN EXCEL Trial Investigators
Apr 1, 2020·The New England Journal of Medicine·John A SpertusUNKNOWN ISCHEMIA Research Group
Apr 1, 2020·The New England Journal of Medicine·David J MaronUNKNOWN ISCHEMIA Research Group

❮ Previous
Next ❯

Citations

Mar 4, 2021·Korean Circulation Journal·Doyeon HwangBon Kwon Koo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.